West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics

West Pharmaceutical Services, Inc. (WST)

Today's Latest Price: $170.16 USD

1.51 (-0.88%)

Updated Feb 21 12:00am

Add WST to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

WST Stock Summary

  • WST's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 285.93 -- higher than 85.79% of US-listed equities with positive expected earnings growth.
  • West Pharmaceutical Services Inc's stock had its IPO on January 5, 1988, making it an older stock than 88.82% of US equities in our set.
  • Price to trailing twelve month operating cash flow for WST is currently 34.82, higher than 88.72% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to WST, based on their financial statements, market capitalization, and price volatility, are TFX, WAB, PRGO, XYL, and GMED.
  • WST's SEC filings can be seen here. And to visit West Pharmaceutical Services Inc's official web site, go to www.westpharma.com.
WST Daily Price Range
WST 52-Week Price Range

WST Stock Price Chart More Charts

WST Price/Volume Stats

Current price $170.16 52-week high $176.66
Prev. close $171.67 52-week low $101.15
Day low $169.76 Volume 307,100
Day high $171.72 Avg. volume 420,580
50-day MA $156.27 Dividend yield 0.38%
200-day MA $140.58 Market Cap 12.59B

West Pharmaceutical Services, Inc. (WST) Company Bio

West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.

WST Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$170.16$47.21 -73%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for West Pharmaceutical Services Inc. To summarize, we found that West Pharmaceutical Services Inc ranked in the 23st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 72.83%. As for the metrics that stood out in our discounted cash flow analysis of West Pharmaceutical Services Inc, consider:

  • Interest coverage, a measure of earnings relative to interest payments, is 34.01; that's higher than 87.45% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than merely 9.84% of the free cash flow producing stocks we're observing.
  • WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 58.48% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as WST, try EW, OFIX, DHR, GKOS, and NEO.

WST Latest News Stream

Event/Time News Detail
Loading, please wait...

WST Latest Social Stream

Loading social stream, please wait...

View Full WST Social Stream

WST Price Returns

1-mo 8.69%
3-mo 16.35%
6-mo 17.32%
1-year 63.94%
3-year 107.79%
5-year 224.16%
YTD 13.31%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%
2015 14.03%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8458 seconds.